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ABSTRACT 
  Organ failure is a devastating condition. Transplant offers the hope of “cure” to many 
patients with end-stage organ failures. The process of organ transplant is highly complicated 
involving  many  stakeholders.  Important  issues,  including  medical,  legal,  administrative  and 
ethical, have to be resolved in order to implement a successful organ transplant system and 
prevent abuses. As such, legislative control of organ transplants is a necessity. 
  Most organ transplant laws cover the donation procedure, types of consent required, 
establishment of the transplant waiting lists, allocation of organs, certification of brain death, 
performance  of  the  transplant  procedure,  and  management  of  post-transplant  issues.  The 
regulatory system in the United States builds on the foundation of individual rights and explicit 
decisions are required for the donation of organs. The operations of the transplant system are 
largely outsourced to the Organ Procurement and Transplantation Network under a contractual 
agreement. In contrast, the Singapore system builds on a presumed consent mechanism where 
residents and citizens are automatically considered as donors upon their death unless they 
have registered an objection. The operations of the transplant system are centrally managed by 
the National Organ Transplant Unit within the Ministry of Health. 
  The two systems reflect the unique social and cultural backgrounds of the two countries 
and they meet the different needs of their people. However, recommendations are made for 
the United States to strengthen its regulatory system in terms of the need to regulate living 
donor organ transplants and expand the role of the Food and Drug Administration to ensure 
the quality and effectiveness of organs and tissues for transplantation.    
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Aim 
  The aim of this paper is to discuss the general principles of organ transplant regulation 
and the need for legislative control of the organ transplant process, from the diagnosis of organ 
failure, setting up of transplant waiting lists, and procurement of organs, to the performance of 
the transplant procedure and management of post-transplant issues. I will then compare the 
two very different organ regulatory systems in the United States and Singapore, and discuss the 
strengths and weaknesses of these two respective systems. 
 Organ Failure 
  Organ failure is a devastating and yet common medical condition. It involves the failure 
of one or more essential organs or systems of the body, causing significant disabilities or even 
death. Organ failure can be a chronic problem requiring long term treatment, resulting in long 
term suffering of the patient and his family members, as well as the burden to pay for the high 
cost  of  treatment.  On  the  other  hand,  it  can  be  a  relatively  acute  problem,  with  rapid 
deterioration of the patient’s condition leading to death within a few weeks. 
  The common types of organ failure are kidney, liver and heart failures. For cornea, most 
medical authorities consider it a tissue and the reason for transplant is usually cornea opacity 
due to physical injuries, and not “failure” of the tissue. The aim of medical treatment is to 
provide “replacement therapy” – treatment that replaces the lost functions of the organ or 
system. To date, the only successful experience in providing replacement therapy is kidney 
dialysis. The other attempts to manage liver (e.g. liver dialysis) and heart failures (e.g. left 2 
 
ventricular assist device; heart reconstruction surgery) have not produced very good results. 
Very often, these patients die relatively quickly even with therapy, unlike kidney failure patients 
who can live with dialysis for many years. 
Organ Transplantation – A New Hope 
  A new hope for organ failure patients is transplantation. This involves taking the organ 
(or part of it, like a lobe of the liver) from another person and implanting it into the patient 
immediately after the diseased organ is removed. One of the biggest medical challenges of 
organ transplantation is graft rejection – the immune system of the patient’s body recognizes 
the  implanted  organ  or  tissue  as  “foreign”  and  acts  to  reject  it.  With  advances  in 
immunosuppressive  therapy,  the  problem  of  graft  rejection  could  be  more  adequately 
controlled. For example, the introduction of cyclosporine by Novartis has greatly boosted the 
success rate of kidney transplantation. 
  Organ transplantation can be seen as a form of “cure” for organ failures as the patient 
receives a new functioning organ, and treatment is not aimed at salvaging or sustaining the 
diseased  or  failing  organ.  Even  for  kidney  failure,  which  can  be  treated  with  dialysis, 
transplantation produces better results compared to dialysis in terms of longer survival and 
fewer complications.
1 For liver and heart failure patients, organ transplant is usually a life-
                                                           
1 Wolfe R A, Ashby V B, Milford E L et al (1999). Comparison of Mortality in All Patients on Dialysis, Patients on 
Dialysis Awaiting Transplantation, Recipients of A First Cadaveric Transplant. New and England Journal of Medicine 
Vol 342 No 23: 1725-1730 3 
 
saving treatment as these patients could only be sustained for a relatively short period of time 
even in the best medical facilities, before they succumb to their diseases. 
  The first successful transplant (cornea) in the world took place in 1905 in now the Czech 
Republic by Eduard Zirm.
2 The first successful kidney transplant was performed in 1954 by 
Joseph Murray in Boston. The first successful liver transplant was performed in 1967 by Thomas 
Starzl in Denver. The first successful pancreas transplant was performed by Ruchard Lillehei and 
William Kelly in Minnesota in 1966. The first successful heart transplant was performed in 1967 
by Christiaan Barnard in Cape Town.
3 Subsequently, other types of transplants were tried and 
many were successfully performed, including lung, intestine, hand, face and even penis. Organ 
transplantation  is  an  effective  therapy  for  end-stage  organ  failure  and  is  widely  practiced 
around the world. According to the World Health Organization, kidney transplants are carried 
out in 91 countries. Around 66 000 kidney transplants, 21 000 liver transplants and 6000 heart 
transplants were performed globally in 2005. The access of patients to organ transplantation, 
however, varies according to their national situations, and is partly determined by the cost of 
health care, the level of technical capacity and, most importantly, the availability of organs.
4 
  Most  solid  organs  for  transplantation  are  taken  from  deceased  persons  (cadaveric 
donors) – this is the safest way as the donor is already dead and will not be subjected to any 
medical risks. However, organs for transplantation must be “fresh” (functioning) and therefore 
                                                           
2 Eye Bank Association of America: http://www.restoresight.org/general/anniversary.htm 
3 Morris P J (2004). Transplantation: A Medical Miracle of the 20
th Century. Medical History Vol 351:2678-2680. 
4 World Health Organization (December 2007). Bulletin of the World Health Organization Vol 85 No 12. 4 
 
timing is critical. It is usually not feasible to take organs from cardiac dead patients (i.e. donor’s 
heartbeat and breathing have stopped) as their organs will rapidly deteriorate and there will 
not be sufficient time to prepare for and perform the transplant. The only exception is cornea, 
which can be taken from deceased patients even several hours after their deaths. For the other 
organs, they have to be taken from brain dead patients i.e. heart-beating donors. Although 
there have been attempts to harvest organs from non-heart-beating donors by a technique 
called “core cooling” (cooling the body rapidly to preserve the organs when the heart stops 
beating), there are tremendous logistic difficulties in implementing this on a large scale basis. 
  Currently there is a worldwide shortage of organs for transplantation. In the United 
States, it is estimated that the waiting list for organ transplant is nearing 100,000. Everyday, 
although there are about 77 people receiving an organ transplant, another 19 people on the 
waiting list die because there are not enough organs for transplantation.
5 
  Besides  taking  organs  from  deceased  people,  organs  can  also  be  taken  from  living 
donors. The first living donor organ transplant was performed in Boston in 1954 involving the 
donation of one kidney to the patient from his twin brother (therefore overcoming the problem 
of graft rejection as immunosuppressive therapy was still undeveloped).
6 In view of the severe 
shortage of organ for transplantation, many countries are encouraging living donor transplants. 
One kidney can be taken out for transplantation from a living person and the donor can live 
                                                           
5 US Department of Health and Human Services: http://www.organdonor.gov 
6  Medical  News  Today  (December  21,  2004).  First  Successful  Living  Donor  Kidney  Transplant  50  Years  Ago. 
http://www.medicalnewstoday.com/articles/18170.php 5 
 
without any significant adverse health effects with the remaining functional kidney. Liver can be 
split and one lobe donated to a patient. Pancreatic cells (Islet cells that produce insulin) can be 
taken out for implantation into type I diabetic patients although this is still considered by many 
as experimental.  
  There are a few other types of “transplants” such as bone marrow transplant and blood 
transfusion,  but  these  are  usually  not  considered  as  the  same  category  as  solid  organ 
transplants  (kidney,  liver  and  heart)  for  regulatory  purposes  because  they  are  readily 
replenished in the body of the donor and the procedures are of very low risk. There are also 
deceased people who donate their bones for use as bone grafts, as well as the whole body for 
educational  (e.g.  anatomical  studies  by  medical  students)  and  research  purposes  (e.g. 
experimental surgery) 
Organ Transplant Process 
  The process to obtain human organs for transplantation is long and tedious, involving 
many different parties such as the patients, their family members, health care professionals, 
third-party payers (e.g. health insurance companies), government (as regulator and funders), 
community  groups  (e.g.  religious  institutions)  and  non-profit  organizations  (e.g.  advocacy 
groups). Besides medical issues, there are also many social and ethical problems associated 
with organ transplants. As such, most countries have set up formal and informal systems to 
manage this process. 
 6 
 
(A) Donor Side: 
  On the donor side, there must be full informed consent to donate (either by the donor 
himself or the next-of-kin). In some countries where there are presumed consent laws on organ 
donation, organs can be harvested from deceased people if they have not registered their 
objection. For living donors, it is even more complicated as the donor is subjected to a certain 
level of risk. The donor operative procedure is a major operation. The Mayo Clinic's transplant 
team  estimates  a  risk  of  0.5%  -  1%  to the  liver  donor's  life.
7  The donor  is  also  at  risk  for 
temporary problems related to the surgical incision and the possibility of blood clots. 
  In the procurement stage, issues such as compromise on medical care of the identified 
donors (who are usually in the dying process), compensation to donor’s family, and meeting 
particular religious requirements (e.g. Muslims must be buried within the same day before 
sunset) must be addressed. The most important non-medical question in organ transplant is 
whether  there  is  any  risk  of  organ  trading,  coercion  or  undue  influence  in  the  donation 
decision-making process. There are complex legal and ethical issues to consider and preventive 
measures are usually in place but difficult to enforced. For living donors, the risk of organ 
trading is especially high and some countries only allow immediate family members as living 
donors to ensure that that the donation is made out of altruistic motives. 
  At the point of harvesting the organ, the most critical issue is brain death certification as 
the doctors must be absolutely sure that the donor is dead as the procedure of removing the 
                                                           
7 http://www.mayoclinic.org/liver-transplant/livingdonorlivertransplant.html 7 
 
organ will kill the donor if he is still alive. Although the brain death concept is accepted and 
treated  to  be  equal  to  cardiac  death  by  international  medical  professional  bodies,  some 
communities (e.g. certain Muslim sects) are still reluctant to accept the brain death concept. In 
practice, difficulty is often encountered when family members are asked to accept that their 
loved ones have died while they could still feel his heart beating. There must be clear protocols 
for the certification of death by designated doctors who are “neutral” to the care of the donor. 
Some  countries  stipulated  specific  sophisticated  tests  (e.g.  cerebral  angiography  and 
radionuclide  scan)  to  ascertain  that  the  brain  has  stopped  functioning  permanently.  The 
transplant team must also carefully evaluate whether the organ is suitable for transplant and 
whether  there  is  a  suitable  recipient.  Infectious  diseases  (e.g.  HIV  and  hepatitis)  must  be 
screened. Finally, after the transplant, issues such as waiver of medical fees for the donor, 
reimbursement of funeral costs, and appreciation to donor’s family must be considered.  
(B) Recipient Side   
  On the recipient side, the steps are equally complicated and many issues have to be 
addressed. First there must be clear diagnostic criteria to determine the patient’s condition and 
different options of treatment must be discussed with the patient. Not all patients are suitable 
for transplant (e.g. too sick, too many co-morbidities, etc), and a decision must be made on 
who can be placed on the transplant waiting list. 
  Generally, the most challenging task comes when an organ is available and decision-
makers have to determine who gets and who does not get that organ. In view of the fact that 
the  demand  for  organs  greatly  outstrips  the  supply  of  organs  for  transplantation,  difficult 8 
 
choices must be made all the time. The most important and obvious factor considered by 
health  care  institutions  and  doctors  is  the  suitability  of  the  recipient  (e.g.  immunologic 
matching and patient’s medical condition). However, there are other issues such as medical 
urgency (e.g. whether a patient who is dying should have priority over a more stable patient 
who also needs the organ for life-saving purposes), age of patient (e.g. whether priority should 
be given to a young working father who is supporting a few dependents instead of a retired 80 
years old person), amount of time spent waiting, and even socioeconomic status (e.g. whether 
priority should be given to a prominent leader of the community who has the potential to make 
important contributions to society instead of an ordinary citizen). 
  After  the  transplant,  issues  such  as  ensuring  affordability  of  long  term 
immunosuppressive therapy and medical follow up must be managed carefully so that the 
efforts of securing and transplanting the organ would not go to waste due to insufficient post-
transplant support. Rehabilitation and psychological care of post-transplant patients are critical 
in reintegrating them back into society and helping them lead a normal life. If there is graft 
rejection, the subsequent care would be even more complicated as the patient may need to be 
re-routed for another transplant and the question of eligibility and priority would be raised in 
view of the long waiting list. Other issues such as discrimination at work and health insurance 
coverage would also have to be addressed, not only for the transplanted patients but also for 
the living donors.  
  Table 1 below summarizes the entire organ transplant process and lists the various 
issues to be considered on the donor side and the recipient side. 9 
 
Table 1: Organ Transplant Process 
Donor    Recipient 
     
Decision to donate 
•  Informed  consent  –  Self-pledging  or 
Next-of-kin 
•  Presumed consent 
•  Risk to living donor 
 
  Diagnosis of organ failure 
•  Diagnostic criteria 
•  Determine severity 
•  Any co-morbidities? 
     
 
Procurement 
•  Compromise medical care to donor? 
•  Prohibition of organ trading 
•  Reasonable compensation 
•  Religious issues 
 
   
Options of therapy  
•  Conservative treatment? 
•  Replacement therapy? 
•  Patient factors (motivation, 
occupation, etc) 
     
 
Harvesting of organs 
•  Brain / cardiac death certification 
•  Designated doctors 
•  Suitability of organs 
•  Screening for diseases 
   
Selection for transplant 
•  Management of waiting lists 
•  Determination of priority: 
-  Medical suitability 
-  Medical urgency 
-  Age 
-  Waiting time 
-  Socioeconomic status? 
 
     
 
Post-harvesting issues 
•  Waive medical fees? 
•  Funeral costs? 
•  Appreciation to family members (e.g. 
medical benefits)? 
   
Post-transplant management 
•  Life-long immunosuppression 
•  Employment, insurance, etc 10 
 
The Need for Legislative Control 
  With  such  a  complicated  process  and  many  difficult  issues  to  be  managed,  organ 
transplant is clearly in need of some form of regulation to protect the interest of patients, 
manage  the  practice  of  health  care  professionals,  and  meet  the  expectations  of  society 
including  the  assurance  of  fairness  and  compliance  with  established  ethical  standards.  The 
potential of abuse is very real as many who are in desperate need of organs may choose to 
obtain them by any means, including exploiting the “vulnerable” population such as the poor 
and those who have difficulty supporting their dependents. Leaving the system to professional 
oversight (e.g. medical organizations) would not be a feasible option. 
  The disparity between the demand and supply of organs for transplantation, as well as 
the fact that the demand is rather inelastic (i.e. the consumers are willing to pay almost any 
price to obtain the goods or services), has promulgated extensive national and local legislations 
and  important  case  laws  in  many  countries.  Although  these  laws  and  regulations  may 
complicate the efforts in obtaining organs, they are generally viewed by legislators, health care 
professionals, and the general public as a necessity. These laws attempt to regulate the scare 
resource (transplantable human organs) and help establish equitable systems to allocate the 
organs where maximum benefits could be obtained, with specific objectives in four main areas: 
1.  Medical    ￿  Safety of patients and effectiveness of transplant 
2.  Legal    ￿  Prevention of abuse and protection of the public 
3.  Administrative  ￿  Equity of allocation and efficiency of the system 
4.  Ethical    ￿  Maintenance of public order and assurance of professionalism 11 
 
Organ Transplant Laws 
  There are major differences in the laws for regulating organ transplants and related 
matters  in  different  countries  but  they  generally  follow  the  same  set  of  objectives  and 
principles. This can be seen by categorizing the main issues to be addressed in these laws: 
(1) Organ Donation 
  The law must specify how consent is to be taken, and if the deceased has not made a 
decision, who (e.g. the specific next-of-kin) has the authority to decide on his behalf. The two 
main consent systems are the opt-in (“informed consent”) system where people have to make 
a pledge to indicate clearly that they wish to be a donor; and the opt-out (“presumed consent”) 
system where people have to indicate and register their objections to be considered as non-
donors – otherwise they will be automatically considered as donors at the time of their death. 
The method for determining death is usually spelt out (e.g. procedure for the certification of 
brain death) for the purposes of removing organs for transplantation from deceased donors. 
  The law will usually also specify which organs or tissues can be harvested and how these 
harvested organs and tissues is to be allocated (e.g. establishing a national prioritized queue 
system for recipients). The law may establish explicit rules or set up special committees to 
determine the allocation of organs. 
  Table  5  below  summarizes  the  laws  for  the  regulation  of  organ  transplants  in  34 
countries. 12 
 
TABLE 2: ORGAN DONATION LAWS IN 34 COUNTRIES 
Country  Informed Consent Law  Presumed Consent Law 
Australia  Law of 1982   
Austria    Law of 1982 
Belgium    Law of 1986 (Families could potentially object) 
Bulgaria    Law of 1996 (In practice consent is sought from 
the next-of-kin) 
Canada  Law of 1980   
Croatia    Law of 2000 (In practice consent is sought from 
the next-of-kin) 
Cyprus    Law of 1987 
Czech Republic    Law of 1984 
Denmark  Current Law of 1990  (Previous Law of 1967) 
Finland    Law of 1985 
France    Law of 1976 (In practice consent is sought from 
the next-of-kin) 
Germany  Law of 1997   
Greece    Law of 1999 
Hungary    Law of 1972 
Ireland  No law, follows UK guidelines   
Israel    Law of 1953 
Italy    Law of 1967 
Japan  Law of 1997 (Before 1997, brain death 
not accepted) (Family can veto) 
 
Luxemburg    Law of 1982 
The Netherlands  Law of 1996   
New Zealand  Law of 1964   
Norway    Law of 1973 (Family consulted and can potentially 
object) 
Poland    Law of 1990 
Portugal    Law of 1993 
Romania  Law of 1998   
Singapore    Law of 1987 (Only Asian country with a presumed 
consent law) 
Slovak Republic    Law of 1994 
Slovenia    Law of 2000 
Spain    Law of 1979 (In practice consent is sought from 
the next-of-kin) 
Sweden    Law of 1996 (Family can potentially veto) 
Switzerland  Law of 1996   
Turkey    Law of 1979 (Only Muslim-dominated country with 
a  presumed  consent  law;  in  practice  consent  is 
sought from the next-of-kin) 
United Kingdom  Laws of 1961 and 1989   
United States  Uniform  Anatomical  Gift  Act  of  1968, 
revised in 1987 
National Organ Transplant Act of 1984  
 
Source: Alberto Abadie and Sebastien Gay (June 2004). The Impact of Presumed Consent Legislation on Cadaveric 
Organ Donation: A Cross Country Study. Kennedy School of Government Working Paper No. RWP04-024. 13 
 
(2) Transplant Procedures  
  The  law  may  stipulate  the  qualifications  of  doctors  who  are  allowed  to  perform 
transplant  procedures.  Many  subsidiary  regulations  specify  how  matching  of  donor  and 
recipient is to be carried out and which infectious diseases are to be tested before an organ can 
be used for transplantation. Some countries also have provisions in their laws to designate 
certain institutions for transplant procedures. The reason for doing this is mainly for quality 
control  and  to  ensure  that  a  sufficient  number  of  cases  are  performed  in  every  center  to 
maintain clinical competence of the transplant teams.  
(3) Organ Trading 
  At  the  Second  Global  Consultation  on  Human  Transplantation  of  the  World  Health 
Organization's  in  March  2007,  it  was  estimated  that  organ  trafficking  (i.e.  patients  went 
overseas  to  purchasing  organs  for  transplantation)  accounted  for  about  5%  of  the  kidney 
transplants performed annually throughout the world.
8 The law will usually ban any form of 
rewards  (except  reimbursement  of  expenses  incurred  in  the  process)  to  living  donors  (e.g. 
people who give away one kidney) or family members of deceased donors as most societies do 
not condone the sale of human organs or tissues. Organ trading is generally considered to be 
unethical except in one country – Iran – which has a legalized system for individuals to sell their 
                                                           
8  Shimazono  Y  (December  2007).  The  State  of  the  International  Organ  Trade:  A  Provisional  Picture  Based  on 
Integration of Available Information. WHO Bulletin Vol 85 No 12. 14 
 
kidneys with a current market price of about US$2,000 to US$4,000. However, there were 
anecdotal reports indicating wide spread exploitation of the poor in this system.
9 
(4) Living Donors 
  Besides  organ  trading,  there  are  many  ethical  issues  involving  live  donors  in 
transplantation. The main concern is the potential risk to the donors. The law will therefore 
specify how the potential donor must be assessed, including psychiatric evaluation to ensure 
that the donor is of sound mind and is fully informed of the nature and consequences of organ 
donation and transplantation, and that the decision is made out of altruism without coercion or 
undue influence. Most laws ban all forms of monetary transactions between the recipient and 
the donor except basic compensation such as traveling costs and loss of income. Sometimes, 
the law allows only closed relatives of the recipient to donate to prevent organ trading.  
(5) Societal Norms 
  In some countries, the law may address issues relating to culture and religion in the 
community  and  accommodate  different  practices.  For  example,  certain  subgroup  of  the 
population may object to organ donation (e.g. Jehovah Witness) or that permission must be 
obtained from certain family members (e.g. Muslims who may be required to obtain permission 
from their waris – the paternal next-of-kin). In some Catholic countries where the opinions of 
the family are considered to be as important as the expressed wish of the deceased, legal or 
                                                           
9  Corwin  J  A  (2005).  Organ  Trafficking  Turns  Poor  /  Rich  into  Supply  /  Demand.  Albion  Monitor 
http://www.albionmonitor.com/0605a/organtraffickrichpoor.html 15 
 
administrative provisions are made in the law to allow family members to veto the decision to 
donate organs made by the deceased. 
(6) Administrative Agency – Some laws assign the duty of regulating organ transplants to the 
usual health authorities (e.g. Ministry / Department of Health) while some establish special 
agencies to administer the laws. For example, in the United Kingdom, a special unit – the 
Human  Tissue  Authority  –  is  set  up  to  oversee  all  organ  transplant  matters  including  the 
approval of living donor organ transplants. In some countries, the law is silent and the relevant 
health authorities could exercise greater flexibility, such as the United States Department of 
Health  and  Human  Services,  that  contracts  with  the  OPTN  (Organ  Procurement  and 
Transplantation Network) to formulate organ transplant policies and coordinate organ donation 
and transplantation. 
Regulation of Organ Transplants in the United States 
  As of April 2008, there are nearly 100,000 people in the United States waiting for an 
organ transplant. The needs for organs and transplants are rising every year. The efficiency and 
effectiveness of the organ transplant system is closely linked to the laws governing it. The key 
feature is the opt-in system for organ donation with operational flexibility at the state level. 
 
Waiting list candidates  99,093   As of Apr 30, 2008 
Transplants January - April 2008  2,197  As of Apr 30, 2008 
Donors January – April 2008  1,132  As of Apr 30, 2008 
Source: Organ Procurement and Transplantation Network (OPTN) data 16 
 
  Following is a survey of the various laws related to the regulation of organ transplants in 
the United States.
10, 11, 12, 13, 14   
1968 – Uniform Anatomical Gift Act 
  There were no federal laws regulating organ and tissue donation before 1968. Organ 
and tissue donations were handled at the state level only. Unfortunately, these state laws 
differed considerably from state to state and caused a lot of confusion. The Uniform Anatomical 
Gift Act was enacted in 1968 to address these problems by providing a framework of uniform 
laws in the United States relating to organ and tissue transplantation. It also attempted to 
increase the number of available organs by making it easier for individuals to pledge as organ 
donors. 
  In 1972, the Uniform “Organ Donor Card” was mandated to be recognized as a legal 
document in all 50 states under the Uniform Anatomical Gift Act. This empowered any person 
aged 18 years and above to legally make a pledge to donate his organs upon death. 
 
                                                           
10  eNotes:  Enclyopedia  of  Everyday  Law:  Organ  Donation.  http://www.enotes.com/everyday-law-
encyclopedia/organ-donation 
11  United  States  Department  of  Health  and  Human  Services.  OrganDonor.Gov:  Access  to  U.S.  Government 
Information on Organ and tissue Donation and Transplantation. http://www.organdonor.gov/ 
12 Donate Life America Website. http://www.donatelife.net/ 
13 Lectric Law Library’s Stacks: Organ Donation. http://www.lectlaw.com/filesh/qfl03.htm 
14 OPTN (Organ Procurement and Transplantation Network) Website. http://www.optn.org/ 17 
 
1984 – National Organ Transplant Act (NOTA) 
  The NOTA establishes the framework for the Organ Procurement and Transplantation 
Network  (OPTN)  at  the  national  level.  The  Scientific  Registry  of  Transplant  Recipients,  a 
government unit within the Public Health Service (Division of Transplantation), oversees the 
contractual arrangements with the OPTN. Under the NOTA, the buying and selling of organs are 
prohibited. However, payment of “the expenses of travel, housing, and lost wages incurred by 
the (living) donor” is expressly permitted in section 301. 
1987 – Uniform Anatomical Gift Act (Amended) 
  This version of the UAGA includes several amendments to the original law enacted in 
1968 aiming to facilitate organ donation by providing a useful and uniform legal environment 
throughout the country. 
1991 – Patient Self-Determination Act 
  The federal Patient Self-Determination Act (PSDA) empowers and promotes the use of 
advance directives such as living wills and durable powers of attorney for health care. The PSDA 
changes key provisions in federal Medicare and Medicaid laws. 
  There are three kinds of documents that may serve as evidence of a person's wish to 
donate his organs in the event of that person's death: 
•  Living  wills:  Detailed  regulations  of  living  wills  are  found  in  state  statutes.  Living  wills 
provide instructions for the person's medical care if he becomes incapacitated or unable to 18 
 
make decisions himself. In most cases, a living will can stipulate that the person's organs or 
tissues be removed and donated for medical purposes if they were found to be suitable. 
Individuals who are making a living will are usually advised to inform their physicians and 
family members.  
•  Durable powers of attorney for health care: A durable power of attorney for health care 
names someone as his "agent" who shall make important decisions on health care matters 
concerning that person should the person become incapacitated. This document can also 
instruct the agent to donate the person's organs or tissues upon the person's death. As with 
living wills, the durable power of attorney for medical care is only useful if the agent, the 
family members and the attending physician of the person are aware of its existence.  
•  Advanced  care  medical  directive:  An  advance  care  medical  directive  (ACMD)  combines 
some features of the living will and the durable power of attorney for health care. An ACMD 
allows individuals to give instructions on the types of care they want to accept or reject in 
different number medical scenarios. These documents need to be created in consultation 
with the physician so that it could be of practical use in medical practice.  
1999 – Organ Donor Leave Act 
  This law makes provisions for donors who are federal employees to enjoy organ donor 




1999 – Organ Procurement and Transplantation Network Final Rule 
  This document sets forth improvements made to the final rule governing the operation 
of the Organ Procurement and Transplantation Network (OPTN) which were published in 1998. 
The purpose of the final rule is to help achieve the most equitable and medically effective use 
of human organs that are donated in trust for transplantation. 
2000 – Children's Health Act 
  This law amends the Public Health Service Act and uses the Organ Procurement and 
Transplantation Network to address the special needs of children under the age of 18 years by 
adopting  criteria,  policies,  and  procedures  that  address  the  unique  healthcare  needs  of 
children, including transplant matters. The law requires the OPTN to carry out studies and 
undertake  projects  to  improve  procedures  for  organ  donation  procurement  and  allocation, 
including those children with special needs, minority groups, and those with limited access to 
transportation. The law also provides for a study to determine the costs of immunosuppressive 
drugs to children and the extent that health insurance plans cover such costs. 
2004 – Organ Donation and Recovery Improvement Act 
  Under this Act, funding is made available to states for the following purposes: 
•  Support  organ  donation  awareness  programs,  public  education  and  outreach  programs 
aiming  to  increase  the  number  of  organ  donors  (including  living  donors),  and  the 
development  of  and  dissemination  of  educational  materials  to  inform  healthcare 20 
 
professionals and other relevant professionals on matters regarding organ, tissue, and eye 
donation; 
•  Enable qualified organ procurement organizations and hospitals to establish programs to 
increase the rate of organ donation; 
•  Provide financial assistance to living donors to help defray travel, subsistence, and other 
incidental non-medical expenses; 
•  Establish mechanisms to evaluate the long-term effects of living organ donation. 
New Donation Laws 
  Many  states  and  other  jurisdictions  are  in  the  process  of  implementing  measures 
designed to make it easier for organ donations to occur. Some of the important changes include 
expanding the list of people who can consent to an unconscious patient becoming a donor and 
making it clear that a person's decision to be an organ donor cannot be revoked by anyone 
else.
15 
Regulation of Organ Transplants in Singapore 
  Singapore is a small island city-state in Southeast Asia with an area of 683 squared 
kilometers (about 3.5 times the size of Washington DC). It was founded as a British trading 
colony in 1819. It joined the Malaysian Federation in 1963 but separated later and became 
independent  in 1965.  Singapore  subsequently became  one  of the  world's  most  prosperous 
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countries with strong international trading links with one of the world's busiest port (in terms 
of tonnage handled) and per capita GDP (US$31,400 in 2006) equal to that of the leading 
nations of West (e.g. UK = US$31,800 in 2006). 
  The size of Singapore population is about 4.5 million people but only 3.5 million people 
are residents and citizens while the rest are mainly foreigners working in Singapore. The three 
main  ethnic  groups  are  Chinese  (77%),  Malay  (14%)  and  Indian  (8%).  The  main  spoken 
languages are Mandarin (35%), English (23%), Malay (14.1%), various forms of Chinese dialects 
(Hokkien 11.4%, Cantonese 5.7%, Teochew 4.9%), and Tamil (3.2%). However, English is the 
administrative  language  and  the  language  of  instruction  used  in  educational  institutions. 
According to the Census of 2000, the main religious groups are: Buddhist 42.5%, Muslim 14.9%, 
Taoist 8.5%, Hindu 4%, Catholic 4.8%, Protestant Christian 9.8%, other 0.7%, and no religion 
14.8%. 
  The first organ donation law in Singapore was passed in 1972 – the Medical (Therapy, 
Education  and  Research)  Act  (MTERA),
16  which  allows  the  donation  of  human  organs  and 
tissues for transplant, medical education (e.g. dissection) and research purposes. This is an opt-
in system. However, from 1972 to 2003, only 55,000 pledges were received despite continuous 
efforts  in  promoting  organ  donation.  Of  these  55,000  pledges,  only  three  became  kidney 
donors (providing 6 kidneys) in the last 30 years, benefiting 6 recipients. This will not address 
the needs of the 1000 new cases of organ failure patients every year. Many patients die or drop 
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out (become unfit for transplant when the disease progresses) from the list while waiting. 
Currently, there are more than 500 people on the transplant waiting list (most are for kidney 
transplant and the numbers for liver and heart transplants are very small as these patients die 
very quickly).  
  In 1987, the Government decided to introduce a different system – the opt-out system – 
under the Human Organ Transplant Act (HOTA).
17 The HOTA is the first and only presumed 
consent organ donation law in Asia. When the law was enacted in 1987, it only covered the 
kidney and deaths from accidents (because these were more acceptable to the public and other 
types of organ transplants were still not fully established yet) and the kidneys harvested could 
only  be  used for  transplant  purposes. People  could  continue to pledge  for  organ donation 
under the MTERA for organs other than the kidney and it would include non-accidental deaths; 
the purposes would include transplant, education and research. 
  With better safety measures implemented and the increasing need for other types of 
organs for transplants (i.e. liver, heart and cornea), the HOTA was amended in 2004 to expand 
its coverage to include the heart, liver and cornea, and all causes of death (instead of accidents 
only). The amendment also added the regulation of living donor organ transplantation (which 
was previously practiced according to professional guidelines issued by the Ministry of Health 
without legislative control). With the expansion of the scope of HOTA, the role of MTERA has 
gradually  diminished.  Currently,  the  HOTA  system  produces  about  30  donors  every  year, 
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implying 60 kidney patients, 30 heart patients, 30 liver patients, and another 30 – 60 cornea 
patients, are benefiting from these “gifts of life”. 
  The HOTA covers all Singapore citizens and permanent residents aged 21 to 60 years. 
The  Act  originally  excluded  Muslims  on  religious  grounds  but  this  was  changed  in  an 
amendment  in  January  2008  and  all  Singapore  residents  and  citizens,  regardless  of  their 
religious affiliations, are now covered under the HOTA. Those who do not wish to be donors 
have to register their objection with the Ministry of Health. Every year, two batches of letters 
will be sent to Singapore citizens and permanent residents who are reaching 21 years old to 
inform them of the need for organ donation to save lives, as well as the details of the presumed 
consent law, including the opt-out mechanism. In order to ensure that the letters reach them, 
the methods of mailing have improved over the years and at present, these letters are sent by 
courier (i.e. by hand) to the addressees so that nobody could claim that he / she is unaware of 
the presumed consent law. Continuous educational programs are also run twice every year to 
coincide with the mailing out of the two batches of notification letters. The programs include 
advertisements in the major newspapers, talks, exhibitions, etc. There are also special events 
such  as  the  annual  game  for  organ  transplant  patients  (i.e.  patients  who  have  received  a 
transplant), which is aimed to demonstrate the new lease of life they receive through organ 
donation and transplantation – a “gift of life” from other people. 
  As a principle of fairness, objectors to the HOTA have lower priority in receiving organs 
harvested  under  the  system  if  they  happen  to  develop  organ  failure.  Before  the  2008 
amendment, Muslims also had lower priority like the objectors unless they had made a pledge 24 
 
to be organ donors under the MTERA opt-in system. For people who are given lower priority 
under the HOTA system, their chances of receiving an organ for transplant if they ever need it, 
are near zero because of the large number of patients who have priority over them in the 
waiting list. 
  The  Singapore  case  is  a  good  example  to  demonstrate  the  impact  of  legislation  in 
helping organ failure patients and saving lives. Table 3 below shows the effects of the 2004 
amendment of the Human Organ Transplant Act on the transplant waiting lists and the number 
of transplants performed.   
Table 3: Effects of the Amendment of the Human Organ Transplant Act in 2004 
Type of Transplant  Number of People on Waiting List  Number of Transplants Performed 
Kidney   •  557 in 2006 
•  Down from the peak of 673 in 
2003 
•  In 2006, 43 live and 53 cadaveric 
transplants performed 
•  In 2003, 18 live and 26 cadaveric 
transplants performed 
Liver  •  12 in 2006 
•  Down from the peak of 22 in 
2003 
•  In 2006, 7 live and 25 cadaveric 
transplants performed 
•  In 2003, 2 live and 17 cadaveric 
transplants performed 
Heart  •  1 in 2006 
•  Down from the peak of 7 in 
2002 
•  In 2006, 6 transplants performed 
•  In 2003, no transplant 
performed 







Comparing the Key Features of the United States and Singapore Systems 
  The organ transplant system in the United States functions on an opt-in basis with a 
coordinated network to allocate organs for transplantation. The network is operated by the 
OPTN  (Organ  Procurement  and  Transplantation  Network),  which  is  contracted  by  the 
Department  of  Health  and  Human  Services.  This  approach  will  have  to  emphasize  public 
outreach and educational efforts to convince as many people as possible to pledge as organ 
donors. 
  The  American  system  reflects  the  long-standing  liberal  democratic  tradition  of  the 
country. It is unlikely to be acceptable to most Americans to implement a presumed consent 
system  involving  the  removal  of  organs  from  individuals  without  their  explicit  consent.  In 
addition,  the  political  philosophy  of  restricting  the  power  of  the  government  has  probably 
restrained the Department of Health and Human Services to play an active role in managing 
organ transplantation, which is seen by many as a clinical issue to be managed at the ground 
level by the professionals.     
  The  Singapore  system,  in  contrast,  functions  on  an  opt-out  basis  with  a  centralized 
National Organ Transplant Unit within the Ministry of Health to manage the transplant waiting 
lists and oversee all transplant processes. The approach is to constantly remind the public of 
the presumed consent law, especially those who are new to the system (i.e. people turning 21 
years old and the new residents of Singapore), and ensure that the harvesting procedure is 
carried out efficiently. 26 
 
  Singapore has a one-party dominated government in the past 30 years. The “aggressive” 
approach is more acceptable to a population that is accustomed to complying with government 
orders. The social culture also places great emphasis on pragmatism and outcome. As such, 
even if the processes may be debatable in terms of respecting individual rights, they are usually 
tolerated by the people if they could produce better outcomes. In this case, the opt-out system 
has  clearly  demonstrated  its  effects  in  boosting  transplant  rates  and  saving  lives.  The 
government has explained publicly that the presumed consent system is a desperate solution to 
a desperate problem.         
    Table 4 below shows the detailed comparison of the two organ transplant regulatory 
systems. 
Table 4: A Comparison of the Organ Transplant Regulatory Systems 
in the United States and Singapore 
Regulatory Areas  United States  Singapore 
Organ Donation  •  Opt-in / Informed consent 
•  Administered at state level 
•  Opt-out / Presumed consent 
•  Administered centrally by the 
Ministry 
Organ Procurement  •  Contracted out to OPTN  •  Centralized unit in the 
Ministry 
Types of organs and 
tissues for Transplant 
•  Not regulated  •  Specified in the legislation 
Living Donor 
Transplant 
•  OPTN policies – best practices 
and voluntary guidelines 
•  Legislated control requiring 
approval of Transplant Ethics 
Committee 
Organ trading  •  Prohibited (reasonable 
compensation allowed) 






  The first and utmost question to ask after comparing the two systems is whether the 
United  State  should  consider  an  opt-out  system  in  view  of  the  increasing  needs  for  organ 
transplant. In the study conducted by Abadie and Gay
18 to assess the impact of presumed 
consent  laws  on  donation  rates,  they  constructed  a  dataset  on  organ  donation  rates  and 
potential factors affecting organ donation for 22 countries over a 10-year period and found that 
while differences in other determinants of organ donation explained much of the variation in 
donation  rates,  after  controlling  for  those  determinants.  They  concluded  that  presumed 
consent legislation had a positive and sizeable effect on organ donation rates. There is great 
support  for  the  presumed  consent  system  in  various  countries,  especially  in  view  of  the 
practical  advantages.  Straw
19  (Founder  and  Chairman  of  the  Organ  Donor  Association  of 
Australia) argues that presumed consent legislation gathers up those who will donate but who 
find the procedures involved too time consuming, whilst at the same time it allows a legitimate 
avenue  for  others  to  deny  their  donation.  His  organization  is  proposing  to  the  Australian 
Government that Australia should adopt the presumed consent system because of its relatively 
low  transplant  rates  and  the  high  cost  of  dialysis  compared  to  transplant.  In  the  United 
Kingdom, about 7,500 people are on the transplant waiting list.
20 About 400 people on the 
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waiting list die each year while waiting for a transplant (excluding those who did not even reach 
the waiting list). The British Government is considering legislative changes to move towards an 
opt-out system. The British Medical Association (BMA) also supports a system of presumed 
consent with safeguards, for those over the age of 16 years, where relatives’ views are taken 
into account. The BMA believes that moving into a system of presumed consent, combined with 
other reforms to the transplant infrastructure, would play an important part in improving the 
organ donation system so that more lives can be saved.
21 In order to gauge the response of the 
public, the BMA recently conducted a survey with 2,000 people in England, Scotland and Wales, 
showing that only about a quarter were on the Organ Donor Register although 62% were willing 
to donate their organs for transplantation after death and 64% were supportive of a presumed 
consent system.
22 The Chief Medical Officer for England, Sir Liam Donaldson, recently called for 
organ donation in England and Wales to move towards an opt-out system.
23  
  Courtney (Vice President of the United States Presumed Consent Foundation) believes 
that implementing an opt-out system is the fastest and least expensive way to reduce the 
shortage  of  organs  for  transplantation  in  the  United  States  with  no  harm  to  anyone.
24  He 
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proposes that a presumed consent policy could be successfully implemented with four areas of 
integral capabilities: (1) notification, education, and awareness; (2) a central registry; (3) proper 
program management; and (4) strong oversight to guard against abuses. The current position of 
the  American  Medical  Association  (AMA)  on  presumed  consent  is  that  the  concept  is  not 
unethical,  but  there  has  to  be  a  foolproof  opt-out  system.
25  Gill  acknowledges  the  ethical 
concerns that people’s organs might be removed against their wishes in an opt-out system 
since some would not bother to register their objections. However, he argues that it is morally 
no worse if we do not remove organs from the bodies of people who wish to donate but did not 
bother to sign up in an opt-in system and he believes there are more people in this category. As 
such he suggests that a policy of presumed consent for organ donation in the United States 
would be a moral improvement over the current system.
26 Davis argues that although increased 
public education to increase consent to donate and maximize opportunities to donate may 
yield modest success, if progress continues at that pace, the gap between supply and demand 
will take years to close and thousands of Americans will continue to die while on organ waiting 
lists. As such, he calls for bold action by government to solve the problem and recommends two 
particular policies: mandated choice (e.g. when a person renews his driver’s license or files an 
income tax return, he would be “forced” to indicate a choice on whether he wants to be a 
donor) and presumed consent.
27 
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  In my opinion, I do not think the presumed consent system would work in the United 
States at this point in time in view of its liberal democratic tradition and the long history of 
respecting individual rights. Although many of the presumed consent systems are found in the 
West – mainly the Western European countries, their societies are different as they are usually 
made  up  of  homogenous  people  with  a  long  history  of  authoritarian  rule  under  various 
monarchs. There has not been sufficient public discussion on this subject in the United States 
and most Americans are probably not aware of the difference between the two systems. Any 
proposal  on  a  presumed  consent  law  would  be  unlikely  to  even  stand  a  chance  for 
consideration by any legislator. However, there should be on-going dialogues and debates on 
this important issue and the opinions of the public should be systematically determined and 
analyzed over time. If there is grater acceptance of a presumed consent system in the future, 
large-scales studies should be carried out to provide information to guide policy-makers.  
  Some have also advocated that the United States should implement a “controlled organ 
trading system” like the one in Iran to solve the acute problem of organ shortage.
28 Prohibition 
of  organ  trading  is  mainly  an  ethical  issue.  The  great  majority  of  human  societies  do  not 
condone the buying and selling or human beings or their parts as this concerns the sanctity of 
the human body and the exploitation of the poor. It is a value cherished by most people and 
lifting the ban is unlikely to gain any significant support from the American public. Moreover, 
the United States is relatively more religious than most developed countries (such as those in 
Europe) and organ trading would be frowned upon by most mainstream religions.  
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  However, in my opinion, there are two other issues which should be considered for 
more formal regulation in the United States: the regulation of living donor organ transplants 
and the regulation of organ and tissues used for transplant purposes. Currently, the Organ 
Procurement  and  Transplantation Network  formulates  policies regarding  living donor  organ 
transplants (except organ trading, which is prohibited under the National Organ Transplant Act 
of  1984).  However,  these  policies  are  only  considered  as  best  practices  or  guidelines  for 
voluntary compliance. There are also more and more complicated and new processes involved 
in living donor organ transplants. For example, U.C.S.F. (University of California, San Francisco) 
runs a “Donor Waiting List Exchange Program” where a donor could donate to a patient on the 
waiting list in exchange of moving his own relative (organ does not match) up the waiting list.
29  
Johns  Hopkins  Comprehensive  Transplant  Center  performed  the  first  “Triple  Swap”  kidney 
transplants in 2003 where 3 different donors exchange their donated kidney so as to find a 
better  match  for  their  respective  relative  on  the  waiting  list.  All  these  initiatives  involve 
significant  risks  and  complicated  operational  and  ethical  issues.  Laws  must  not  lag  behind 
practice too long. It is timely to consider legislative control for living donor organ transplants in 
the United States where most of these new cutting-edge initiatives take place.   
  The last issue is the regulation of organ and tissues used for transplant purposes. The 
United States has one of the most advanced and comprehensive regulatory systems in the 
world  for  drugs,  medical  devices,  and  biologics.  Human  organs  and  tissues  implanted  into 
human bodies for therapeutic purposes cannot be considered to be different from drugs and 
                                                           
29  UCSF  Medical  Center.  Specialized  Services:  Kidney  Donor  waiting  List  Exchange. 
http://www.ucsfhealth.org/adult/special/k/27285.html 32 
 
biologics.  There  are  many  reports  regarding  transplant-acquired  infections  including  AIDS, 
hepatitis  and  dengue,  which  was  first  reported  in  Singapore  in  2005.
30  The  quality  and 
effectiveness of organs and tissues affects the outcome of transplants directly and these organs 
and tissues should therefore be formally regulated. The regulation should cover the screening 
for  infectious  diseases,  sources  of  organs  (local  and  overseas,  as  well  as  animal  sources  – 
“xenotransplantation”), methods for obtaining the organs and their transportation, conditions 
for preservation and storage, and indications for use. The Food and Drug Administration (FDA) 
should play a more active role in the regulation of organ and tissues in these areas. However, 
there must be clear legislative support for FDA to perform these functions. 
Conclusion 
  Organ transplant is the ultimate hope to many who have end-stage organ failures. To 
some, it is a life-saving procedure. However, taking and implanting the organ from one human 
being  to  another  is  a  highly  complicated  and  sensitive  subject.  It  involves  medical,  legal, 
administrative  and  ethical  issues  that  must  be  resolved  before  society  could  accept  the 
practice. Very often, the cultural values and religious practices in a particular community will 
have important influence on its system of organ transplant regulation. 
  The main objective of legislation is to protect public interest and maintain public order. 
The outcomes policy-makers hope to see are the increased availability of human organs for 
transplantation  so  as  to  relieve  suffering  and  save  lives,  and  the  proper  performance  of 
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transplants in an orderly and acceptable manner in the context of the local community. As such, 
establishing laws to regulate organ transplants is a highly sensitive and political exercise that 
must be handled with care. A balanced system should be created that is clinically effective 
(meeting  patients’  needs),  legally  sounds  (maintaining  order),  administratively  efficient 
(achieving good quality at affordable costs), and ethically acceptable (resulting in a harmonious 
society).          
  The  rationales  for  regulating  organ  transplants  are  well  established.  However,  the 
systems adopted in different countries or even at different regions within a country can be 
vastly different. They reflect the different value systems in these societies. The United States, 
having a liberal democratic tradition and a strong belief in individual rights, adopts a system 
based on clear individual conviction for organ donation. In Singapore where there is a strong 
trust  in  the  government  /  establishment  where  people  comply  readily  with  governmental 
policies and consider societal goals to be above personal rights, a presumed consent system is 
adopted. The unique background in each of the two countries explains the different approach 
adopted. Although the presumed consent system is generally considered to be more effective 
in increasing the supply of organs for transplantation, it would not be prudent to impose this 
system on any country. Each society must decide for itself what is acceptable, and accept the 
consequences.  These  are  difficult policy  choices  and  trade-offs  inevitably  have  to  be  made 
regardless of which system a country decides to adopt.       
  However,  there  are  certain  universal  regulatory  principles  that  could  be  applied 
regardless of the type of regulatory system adopted. One example is the regulation of organs 34 
 
and tissues for transplantation. In this regard, the objective is simple and straightforward – to 
protect  the  patients.  The  United  States  should  consider  a  more  comprehensive  regulatory 
system for such “health products”. With the appropriate legislative backing, the role of the FDA 
should be expanded to cover this area. 
 
[END] 